Vericel Corporation (VCEL)
After hours:
| Previous Close | 46.42 |
| Open | 46.51 |
| Bid | 46.05 x 200 |
| Ask | 46.15 x 200 |
| Day's Range | 46.04 - 46.87 |
| 52 Week Range | 30.16 - 53.05 |
| Volume | |
| Avg. Volume | 441,788 |
| Market Cap | 2.246B |
| Beta (5Y Monthly) | 1.73 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53.90 |
GlobeNewswireVericel to Report First-Quarter 2024 Financial Results on May 8, 2024
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first-quarter 2024 financial results on Wednesday, May 8, 2024. Vericel’s management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel webs
Simply Wall St.Vericel Corporation (NASDAQ:VCEL) On The Verge Of Breaking Even
With the business potentially at an important milestone, we thought we'd take a closer look at Vericel Corporation's...
GuruFocus.comDirector ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL)
Director ZERBE ROBERT L MD has sold 3,278 shares of Vericel Corp (NASDAQ:VCEL) on March 27, 2024, according to a recent SEC filing.
